Mosaic ImmunoEngineering (CPMV) Equity Income (2012 - 2019)

Mosaic ImmunoEngineering's Equity Income history runs 7 years deep, the most recent figure standing at -$58013.0 for Q4 2019.

• In Q4 2019, Equity Income fell 96.75% year-over-year to -$58013.0; the TTM figure through Nov 2019 stood at -$205683.0 (down 194.14% YoY), while the FY2013 annual figure was $4.3 million, up 218.92% from the prior year.
• Equity Income for Q4 2019 stood at -$58013.0, up from -$88625.0 in the prior quarter.
• The five-year high for Equity Income was $538628.0 in Q1 2015, with the low at -$261106.0 in Q1 2016.
• The 4-year median for Equity Income is -$43786.0 (2018), against an average of $11973.2.
• The sharpest annual moves came in 2015 and 2019: Equity Income jumped 1001.06% in 2015, then tumbled 199.82% in 2019.
• Mosaic ImmunoEngineering's Equity Income stood at $538628.0 in 2015, then slumped by 148.48% to -$261106.0 in 2016, then surged by 88.71% to -$29486.0 in 2018, then sank by 96.75% to -$58013.0 in 2019.
• Business Quant data shows CPMV's Equity Income at -$58013.0 in Q4 2019, -$88625.0 in Q3 2019, and -$29486.0 in Q4 2018.